1179329-83-9

Upstream product

• 1006899-36-0 1-(2-amino-4-fluorobenzyl)-3-(4-fluoro-3-trifluoromethyl-phenyl)-5,5-dimethylimidazolidine-2,4-dione 
• 147000-89-3 N-tert-butyloxycarbonylsulfamoyl chloride 
• 20274-69-5 (4-fluoro-3-nitrophenyl)methanol 
• 76437-44-0 1-(bromomethyl)-4-fluoro-2-nitrobenzene 
• 70842-04-5 5,5-dimethyl-3-(α,α,α,4-tetrafluoro-m-tolyl)hydantoin 
• 1179329-78-2 1-(4-fluoro-2-nitrobenzyl)-3-(4-fluoro-3-trifluoromethylphenyl)-5,5-dimethylimidazolidine-2,4-dione 
• 446-10-6 2-nitro-4-fluorotoluene 

Downstream Products

• 1179329-84-0 N-{5-fluoro-2-[3-(4-fluoro-3-trifluoromethylphenyl)-5,5-dimethyl-2,4-dioxoimidazolidin-1-ylmethyl]phenyl}sulfamide 
• 1179329-52-2 1-{5-fluoro-2-[3-(4-fluoro-3-trifluoromethylphenyl)-5,5-dimethyl-2,4-dioxoimidazolidin-1-ylmethyl]phenyl}-3-(4-methanesulfonylphenyl)sulfamide 

Relevant academic research and scientific papers

Novel phenyl-substituted imidazolidines, process for preparation thereof, medicaments comprising said compounds and use thereof

The invention relates to compounds of formula (I) wherein the groups have stated meanings, and to their physiologically compatible salts. Said compounds are suitable, for example, as anti-obesity drugs and for treating cardiometabolic syndrome.

Arylchalcogenoarylalkyl-substituted imidazolidine-2,4-diones, process for preparation thereof, medicaments comprising these compounds and use thereof

The invention relates to compounds of formula (I) wherein the groups R and R′, A, D, E, G, L, p and R1 to R10 have the stated meanings and to their physiologically compatible salts. Said compounds are suitable, for example, as anti-obesity drugs.